Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study.
Hata H, Imamachi K, Ueda M, Matsuzaka M, Hiraga H, Osanai T, Harabayashi T, Fujimoto K, Oizumi S, Takahashi M, Yoshikawa K, Sato J, Yamazaki Y, Kitagawa Y.
Hata H, et al. Among authors: ueda m.
Support Care Cancer. 2022 May;30(5):4505-4514. doi: 10.1007/s00520-022-06839-4. Epub 2022 Feb 3.
Support Care Cancer. 2022.
PMID: 35113225